RELIANCE LIFE
GenericsRELIANCE LIFE is a generic drug manufacturer focused on Oncology, Gastroenterology.
Upcoming FDA Decisions
Full Calendar →RELIANCE LIFE's Key Drugs
RELIANCE LIFE's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
RELIANCE LIFE's Recent FDA Approvals
New NDA/BLA approvals for RELIANCE LIFE over the last two years — novel drugs only, excluding generics and label supplements.
RELIANCE LIFE's Therapeutic Areas
RELIANCE LIFE's approved drugs and pipeline span 2 therapeutic areas, led by Oncology and Gastroenterology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
RELIANCE LIFE's Top Competitors
RELIANCE LIFE's closest competitors by therapeutic-area and drug-target overlap include Johnson & Johnson, Bristol-Myers Squibb, and Takeda. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
RELIANCE LIFE Pipeline Snapshot
Active clinical trials for RELIANCE LIFE across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Oncology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2020-04-27
- Latest
- 2025-10-09
- Applications
- 3